Insider Shareholders with Direct Ownership of Tcr2 Therapeutics Inc. (TCRR)
This section provides a comprehensive overview of the insiders with direct ownership of Tcr2 Therapeutics Inc. (TCRR). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
TCR2 THERAPEUTICS INC. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Mpm Asset Management Llc
> 10% Shareholder |
178,269 | 70,170 | 304,001 $0 | 2 |
May 22, 2023
Reduced 18.75%
|
|
Robert Hofmeister
Chief Scientific Officer |
47,000 | 40,000 | 45,850 $0 | 5 |
Dec 22, 2020
Added 13.25%
|
|
Mayur Ian Somaiya
Chief Financial Officer |
4,000 | 5,666 | 1,473 $0 | 4 |
Dec 14, 2020
Reduced 57.59%
|
|
Garry E Menzel
President and CEO |
399,723 | 401,990 | 0 $0 | 16 |
Jun 01, 2023
Reduced 100.0%
|
|
Alfonso Quintas Cardama
Chief Medical Officer |
140,375 | 142,300 | 0 $0 | 14 |
Jun 01, 2023
Reduced 100.0%
|
|
Angela Justice
Chief People Officer |
69,269 | 69,269 | 0 $0 | 13 |
Jun 01, 2023
Reduced 100.0%
|
|
Peter Olagunju
Chief Operating Officer |
33,409 | 35,601 | 0 $0 | 10 |
Jun 01, 2023
Reduced 100.0%
|
|
Ubs Oncology Impact Fund L.P.
> 10% Shareholder |
3,370,982 | 3,370,982 | 0 $0 | 2 |
Jun 01, 2023
Reduced 100.0%
|